Cephalon, Inc. (CEPH) Completes Acquisition Of Ception Therapeutics
4/6/2010 11:14:14 AM
More...
|
Cephalon, Inc. (CEPH) (JOBS) Exercises its Option to Acquire Ception Therapeutics for at least $250 Million
2/23/2010 6:31:09 AM
More...
|
Cephalon, Inc. (CEPH) Signs Option Agreement to Acquire Ception Therapeutics; Cephalon Will Pay Ception $100 Million Upfront
1/14/2009 6:36:00 AM
More...
|
Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children FDA Also Grants Orphan Drug Status to Reslizumab for Pediatric EE
3/5/2008 7:34:49 AM
More...
|
Ception Therapeutics (Jobs) Raises Additional $14.7 Million Bringing Total Series C Financing to $77 Million
5/31/2007 9:44:24 AM
More...
|
Ception Therapeutics Raises $63 Million In Series C Financing
1/30/2007 10:14:51 AM
More...
|